Campbell David Alan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$6.5M

Insider Activity of Campbell David Alan

According to the SEC Form 4 filings, Campbell David Alan, being in a position of

  1. President and CEO at Janux Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8072 shares for $110,829,
    over all time since 2024-09-27, has bought 0 shares, and sold 128072 shares for $6.61M.

Biography of Campbell David Alan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$110,8291100

Comparison of Insiders on Amount of Buys and Sells

2026-01-02SaleJanux Therapeutics, Inc.
JANX
President and CEO
8,072
0.0134%
$13.73$110,829+9.19%
2025-01-07SaleJanux Therapeutics, Inc.
JANX
President and CEO
5,000
0.009%
$60.00$300,004-55.35%
2024-12-24SaleJanux Therapeutics, Inc.
JANX
President and CEO
25,000
0.0433%
$56.19$1.4M-53.29%
2024-12-03SaleJanux Therapeutics, Inc.
JANX
President and CEO
15,000
0.0317%
$67.00$1M-54.98%
2024-11-25SaleJanux Therapeutics, Inc.
JANX
President and CEO
25,000
0.0505%
$51.60$1.29M-44.69%
2024-10-28SaleJanux Therapeutics, Inc.
JANX
President and CEO
25,000
0.0486%
$53.54$1.34M-50.15%
2024-09-27SaleJanux Therapeutics, Inc.
JANX
President and CEO
25,000
0.0476%
$46.31$1.16M-34.21%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.